INMB stock forecast
Our latest prediction for INmune Bio, Inc.'s stock price was made on the Jan. 27, 2020 when the stock price was at 4.82$.
In the short term (2weeks), INMB's stock price should underperform the market by -3.30%. During that period the price should oscillate between -12.57% and +12.46%.
In the medium term (3months), INMB's stock price should underperform the market by -4.77%. During that period the price should oscillate between -43.46% and +32.26%.Get email alerts
Create a solid portfolio with INMB
About INmune Bio, Inc.
INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.67$ per share.
The book value per share is 1.70$
Three months stock forecastJan. 27, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|